期刊文献+

盐酸法舒地尔治疗冠心病不稳定性心绞痛的疗效观察 被引量:4

Therapeutic effect of Fusudil hydrochloride injection in treatment of unstable angina in coronary heart disease
下载PDF
导出
摘要 目的观察Rho激酶抑制剂盐酸法舒地尔治疗不稳定性心绞痛(UAP)的疗效。方法将76例不稳定心绞痛患者随机分为治疗组和对照组,每组38例,治疗组在常规治疗基础上给予盐酸法舒地尔,观察两组治疗前后的临床疗效和心电图变化,hs-CRP、BNP值及其他临床状况。结果治疗组总有效率为92.0%,而对照组为73.7%,两组比较差异有统计学意义(P<0.05)。治疗后治疗组心电图与对照组比较,各项指标均明显改善(P<0.05),hs-CPR、BNP值与对照组比较下降更明显(P<0.05)。结论盐酸法舒地尔治疗不稳定型心绞痛疗效确切。 Objective To investigate the curative effect and safety of Fasudil hydrochloride used in unstable angina. Methods 76 cases of unstable angina were divided into two groups which were the treatment group and the control group, 38 cases in each group, the treatment group was treated by Fasudil hydrochloride on the base of commom treatment. The clinical efficacy of the two groups before and after treatment,including ECG curative effect,hs-CRP,BNP value and other clinical conditions were observed. Results The total efective rate in treatment group was 92.0%,the control group was 73.7%,there was significant difference comparing the treatment group with the control group,(P0.05).After the treatment,each index of ECG improved significantly compared with the control group,(P0.05).And the hs-CPR,BNP value in treatment group decreased significantly comparing with the control group,(P0.05). Conclusion The fasudil hydroehloride in treatment of unstable angina is effective and safe and worth of spreading and further studying.
出处 《中国现代药物应用》 2011年第19期7-8,共2页 Chinese Journal of Modern Drug Application
关键词 盐酸法舒地尔 冠心病 不稳定性心绞痛 疗效 Fasudil hydrochloride Coronary heart disease Unstable angina Therapeutic effect
  • 相关文献

参考文献4

  • 1刘国仗,吴宁,胡大一,陶萍,诸骏仁,郭林妮,郭静萱,游凯.心血管药物临床试验评价方法的建议[J].中华心血管病杂志,1998,26(6):405-413. 被引量:473
  • 2张明,孙晓川.法舒地尔的药理作用及其临床应用的研究进展[J].山西医科大学学报,2007,38(4):369-373. 被引量:71
  • 3Otsuka T, Ibuki C,Suzuki T,et al. Administration of the Rho-ki- nase inhibitor Fasudil to wing nitroglycerin additionally dilates the site ofcomnary spasmin patients with vasospastie angina. Coronary Artery disease ,2008,19 : 105-110.
  • 4Vicari RM,Chaitman B,Keefe D,et al. Efficacy and safety of fasu- diI in patients with stable angina: a double blind, placebo con- trolled, phase 2 trial. J Am Coll Cardiol, 2005, 11 ( 46 ) : 1803-1811.

二级参考文献39

  • 1团体著者,中华心血管病杂志,1996年,24卷,328页
  • 2Shimokawa H,Hiramori K,linuma H,et al.Anti-anginal effect of Fasudil,a Rho-kinsse inhibitor,in patients with stable effort angina:A multicenter study[J].J Cardiovasc Pharmacol,2002,40(5):751-761.
  • 3Fukumoto Y,Matoba T,Ito A,et al.Acute vasodilator effect of a Rho-kinase inhibitor,fasudil,in patients with severe pulmonary hypertension[J].Heart,2005,91:391-392.
  • 4Ishikura K,Yamada N,Ito M,et al.Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension[J].Circ J,2006,70(2):174-178.
  • 5Masumoto A,Hirooka Y,Shimokawa H,et al.Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans[J].Hypertension,2001,38(6):1307-1310.
  • 6Kishi T,Hirooka Y,Masumoto A,et al.Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure[J].Circulation,2005,111:2741-2747.
  • 7Uehata M,Ishizaki T,Satoh H,et al.Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension[J].Nature,1997,389:990-994.
  • 8Somlyo AP,Somlyo AV.Ca^2+ sensitivity of smooth muscle and non-muscle myosin Ⅱ:Modulated by G proteins,kinases,and myosin phosphatase[J].Physiol Rev,2003,83:1325-1358.
  • 9Wettschureck N,Offermanns S.Rho/Rho-kinase mediated signaling in physiology and pathophysiology[J].J Mol Med,2002,80:629-638.
  • 10Satoh S,Utsunomiya T,Tsurui K,et al.Pharmacological profile of hydroxy fasudil as a selective Rho kinase inhibitor on ischemic brain damage[J].Life Sci,2001,69(12):1441-1453.

共引文献542

同被引文献36

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部